Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma (vol 80, pg 1007, 2020)

首页> 外文期刊>Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts >Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma (vol 80, pg 1007, 2020)

【24h】

Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma (vol 80, pg 1007, 2020)

机译：脂质体IRINOTECAN：转移性胰腺腺癌（VOL 80，PG 1007,2020）中的综述

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The article Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma, written by James E. Frampton, was originally published Online First without Open Access.

机译：该文章脂质体伊金替康：由James E. Frampton撰写的转移性胰腺癌腺癌的评论最初在线发布，没有开放访问。

著录项

来源
《Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts》 |2020年第11期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma (vol 80, pg 1007, 2020) [J] . Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2020,第11期

机译：脂质体IRINOTECAN：转移性胰腺腺癌（VOL 80，PG 1007,2020）中的综述
2. Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma [J] . Lamb Yvette N., Scott Lesley J. Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2017,第7期

机译：脂质体IRINOTECAN：转移性胰腺炎腺癌的综述
3. Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study [J] . Yung‐Jue Bang, Chung‐Pin Li, Kyung‐Hun Lee, Cancer science. . 2020,第2期

机译：亚洲患者转移性胰腺腺癌中的脂质体Irinotecan：Napoli-1研究的亚组分析
4. ZNF300 may influence the metastatic properties in pancreatic ductal adenocarcinoma. [D] . Fisher, Amanda. 2014

机译：ZNF300可能影响胰腺导管腺癌的转移特性。
5. Correction to: Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma [O] . James E. Frampton -1

机译：校正至：脂质体伊立替康：转移性胰腺腺癌综述
6. PCN80 BUDGET IMPACT IN THE USA OF LIPOSOMAL IRINOTECAN AS A POST-GEMCITABINE TREATMENT OPTION FOR PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA (MPC) [O] . O. Herrera-Restrepo, C. Ferrufino, S.P. Bilir, 2019

机译：PCN80在美国脂质体Irinotecan的预算冲击作为转移性胰腺腺癌患者的吉西他滨治疗选择（MPC）

Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma (vol 80, pg 1007, 2020)

摘要

著录项

相似文献

相关主题

期刊订阅